Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study.

Jenny DimakosYing CuiRobert W PlattChristel RenouxKristian B Filion Antonios Douros

Published in: Diabetes, obesity & metabolism (2024)

In patients using second-generation sulphonylureas, fluoroquinolones were not associated with an increased risk of severe hypoglycaemia compared with amoxicillin. An increased risk among younger adults is possible.

Keyphrases

end stage renal disease
type diabetes
ejection fraction
newly diagnosed
early onset
chronic kidney disease
peritoneal dialysis